HB1099

Passed Origin

Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

House BillTaylor Rehfeldt(R)Tom Pischke(R)Introduced Jan 21, 2026Last action Feb 25, 2026

This bill creates an exception to South Dakota's ban on psilocybin (a hallucinogenic drug) to allow FDA-approved psilocybin medications in a specific crystalline form to be reclassified as Schedule IV controlled substances instead of Schedule I. Currently, all psilocybin is prohibited under state law, but this change would permit medical use of FDA-approved psilocybin drugs while keeping recreational psilocybin illegal.

AI-generated summary

Changes to Existing Law

This bill does not directly amend codified state law.

History (9)

Feb 26, 2026S
Senate Remove from Consent Calendar S.J. 412
Feb 25, 2026S
Health and Human Services Certified uncontested, placed on consent S.J. 21
Feb 25, 2026S
Health and Human Services Do Pass Passed, YEAS 6, NAYS 0. S.J. 21
Feb 25, 2026S
Health and Human Services Scheduled for hearing S.J. 1
Feb 10, 2026S
First read in Senate and referred to Senate Health and Human Services S.J. 234
Feb 9, 2026H
House of Representatives Do Pass Passed, YEAS 58, NAYS 7. H.J. 265
Feb 5, 2026H
Health and Human Services Do Pass Passed, YEAS 13, NAYS 0. H.J. 13
Feb 5, 2026H
Health and Human Services Scheduled for hearing H.J. 1
Jan 21, 2026H
First read in House and referred to House Health and Human Services H.J. 104